Case Details
- Citation: [2018] SGHC 204
- Title: Public Prosecutor v Saridewi Binte Djamani & Anor
- Court: High Court of the Republic of Singapore
- Criminal Case No: Criminal Case No 28 of 2018
- Date of Decision: 14 September 2018
- Judges: See Kee Oon J
- Plaintiff/Applicant: Public Prosecutor
- Defendant/Respondent: Saridewi Binte Djamani (1) and Muhammad Haikal Bin Abdullah (2)
- Procedural History: Joint trial; convictions and sentencing delivered on 6 July 2018; full grounds issued on 14 September 2018
- Legal Areas: Criminal Law; Misuse of Drugs Act; Evidence; Criminal Procedure
- Statutes Referenced: Misuse of Drugs Act (Cap 185, 2008 Rev Ed) (“MDA”); Criminal Procedure Code (Cap 68, 2012 Rev Ed) (“CPC”)
- Key Provisions (as reflected in the extract): MDA ss 5(1)(a), 5(2), 17, 18(2); CPC s 267(1)
- Cases Cited: [2003] SGCA 17; [2017] SGHC 154; [2017] SGHC 262; [2018] SGHC 204; [2018] SGHC 23
- Judgment Length: 57 pages; 17,855 words
Summary
Public Prosecutor v Saridewi Binte Djamani & Anor ([2018] SGHC 204) is a High Court decision arising from a joint trial for diamorphine trafficking offences under the Misuse of Drugs Act (Cap 185, 2008 Rev Ed) (“MDA”). The court found that the prosecution proved beyond a reasonable doubt that Saridewi possessed not less than 30.72 grams of diamorphine, and that Haikal delivered two packets containing not less than 28.22 grams of diamorphine to her. The convictions followed after the court accepted the prosecution’s evidence on the chain of drug exhibits and the operation leading to the arrests.
The decision is particularly instructive on how the court evaluates (i) challenges to the admissibility and integrity of drug exhibits, (ii) the reliability of accused persons’ investigative statements, including issues relating to mental state during statement recording, and (iii) the statutory presumptions of trafficking and knowledge under the MDA, including whether the defence of consumption can rebut those presumptions. The court ultimately rejected the defences advanced by both accused persons and upheld the prosecution’s case.
What Were the Facts of This Case?
The agreed facts tendered at the beginning of the trial under s 267(1) of the Criminal Procedure Code (Cap 68, 2012 Rev Ed) (“CPC”) established the broad operational and evidential background. The Central Narcotics Bureau (“CNB”) received information about a drug transaction to take place at Block 350, Anchorvale Road, Singapore, on 17 June 2016. CNB officers conducted a covert operation, deploying officers in the vicinity and using measures intended to reduce the risk of the operation being uncovered.
At about 3.35pm, Haikal drove a motorcycle into the carpark of Block 350. After parking, he retrieved a white plastic bag from the motorcycle and went to the lift area. He took the lift to the 17th floor, where he met Saridewi. The CCTV footage captured their movements clearly. Haikal handed Saridewi a white plastic bag, and Saridewi in return handed him an envelope marked “10.000”. The two then separated: Haikal returned to the motorcycle, while Saridewi went to her unit at #16-143 of Block 350.
Shortly after Haikal rode off, CNB officers intercepted and arrested him at the junction of Anchorvale Road and Anchorvale Street. In his possession, officers recovered an envelope marked “10.000” (later marked “MHA-1”) containing cash totalling SGD$10,050, and a brown envelope (later marked “MHA-2”) containing cash totalling SGD$5,500. Officers also seized three mobile phones from Haikal and sent them to the Forensic Response Team (“FORT”) for analysis. Meanwhile, CNB officers proceeded to Saridewi’s unit. When Saridewi heard movements and voices outside her door, she threw various items out of the kitchen window. Before CNB officers could cut through a metal grille gate, she opened the door to allow entry.
Inside the unit, CNB seized a range of items, including packets of crystalline substance, numerous glass tubes, a slab of tablets, numerous empty packets and straws, unused envelopes, a digital weighing scale, a heat sealer, and a notebook. CNB also recovered from the construction site adjacent to Block 350 a white “SKP” plastic bag (marked “A1”) containing another white “SKP” plastic bag (marked “A1A”), which contained two plastic packets (marked “A1A1” and “A1A2”), each containing granular/powdery substance (marked “A1A1A” and “A1A2A” respectively). On the ground floor of Block 350, officers recovered additional stained packets (marked “B1”), loose granular substance (marked “C1”), and further packets and straws (marked “D1”, “D1A”, “D2A”, “D3A”).
It was not disputed that the integrity and custody of all exhibits seized from Haikal and Saridewi were not compromised at any point in time. The Health Sciences Authority (“HSA”) analysed the drug exhibits and found that the total amount of diamorphine contained in the relevant exhibits was not less than 30.72 grams. The DNA analysis showed, among other things, that Haikal’s DNA profile was found on the exterior and interior surface of exhibit “B1” (the two stained packets). Seven investigation statements were recorded from Haikal and Saridewi respectively. While there was no challenge to voluntariness, both accused persons challenged the accuracy of certain portions of their statements.
What Were the Key Legal Issues?
The first major issue concerned the admissibility and reliability of the evidence, particularly the “chain of drug exhibits”. The defence challenged the prosecution’s evidence on the basis that the seized drugs were not necessarily the same drugs that were delivered during the transaction, and raised concerns about whether the covert operation could have led to contamination or substitution of exhibits by other persons in the vicinity.
The second issue related to the accused persons’ mental state during statement recording and the impact of that mental state on the accuracy of their investigative statements. Saridewi’s defence, as reflected in the extract, involved arguments that she may not have had the mental ability to give an accurate version of events during statement taking due to mental conditions. A defence psychologist, Dr Julia Lam, gave opinions about persistent depressive disorder and severe amphetamine-type substance use disorder, and the defence sought to use those opinions to undermine the weight to be placed on Saridewi’s statements.
The third issue concerned the statutory presumptions under the MDA. For Saridewi, the prosecution relied on the presumption of trafficking in s 17 of the MDA, arguing that possession of the diamorphine meant it was presumed to be for the purpose of trafficking unless rebutted. Saridewi sought to rebut the presumption by advancing a defence of consumption, including challenging the prosecution’s evidence on the rate and frequency of consumption and pointing to alleged inconsistencies and admissions. For Haikal, the prosecution relied on s 18(2) of the MDA, which presumes knowledge of the nature of the substance delivered, unless rebutted on a balance of probabilities.
How Did the Court Analyse the Issues?
The court began by addressing the evidential foundation of the prosecution’s case. A central feature was the CCTV footage showing the exchange between Haikal and Saridewi on the 17th floor of Block 350. The court noted that the movements captured on CCTV were clear and not disputed when the footage was viewed during the trial. This supported the prosecution’s narrative that Haikal delivered a white plastic bag to Saridewi and received the envelope marked “10.000” in return.
On the chain of drug exhibits, the court accepted that the integrity and custody of the exhibits were not compromised. The prosecution’s case was that the white “SKP” plastic bag retrieved along with the diamorphine inside was the exact one delivered by Haikal to Saridewi. The defence’s suggestion that someone else in Block 350 might have thrown down exhibit A1 during the covert operation was rejected as implausible. The court reasoned that the CNB operation was covert and designed to reduce the risk of discovery, including the use of unmarked vehicles and CNB officers dressed in civilian clothes. In that context, the court found it unlikely that an unrelated person would have had the opportunity or motive to substitute or introduce the relevant exhibits.
Turning to the statement evidence, the court considered the defence psychologist’s opinions and the prosecution’s critique of those opinions. The extract indicates that Dr Lam opined that Saridewi “might not have the mental ability to give an accurate version of events during the statement taking process” because of her mental conditions. The prosecution argued that Dr Lam’s opinions were flawed, and that the evidence did not show that Saridewi was suffering from drug withdrawal or persistent depressive disorder at the time the statements were recorded. The court’s approach, as reflected in the extract, was to assess whether there was substantial impairment of Saridewi’s mental state when the statements were taken. The court ultimately did not accept that the mental state evidence sufficiently undermined the reliability of the statements, and it placed weight on the statements as part of the prosecution’s proof.
On the statutory presumptions, the court applied the MDA framework. For Saridewi, the prosecution invoked s 17, presuming trafficking based on possession of diamorphine. The court then considered whether Saridewi had rebutted the presumption by establishing, on the balance of probabilities, that the diamorphine was for consumption rather than trafficking. The extract shows that Saridewi’s defence of consumption was challenged on multiple fronts: inconsistencies as to the rate of consumption, contrary admissions in statements and during investigations, the number of days the supply was meant for and the frequency of supply, and financial means. The court also evaluated whether the lies alleged by the prosecution satisfied the “Lucas criteria” (a reference to the principle that lies can support an inference of guilt if certain conditions are met, typically involving whether the lies relate to material matters and demonstrate consciousness of guilt).
For Haikal, the court relied on the presumption of knowledge under s 18(2) of the MDA. The prosecution pointed to Haikal’s cautioned statement indicating he knew what he passed to Saridewi was “drugs”, and to his furnishing of contact numbers of persons said to be related to “drugs”. The prosecution also relied on the pattern of deliveries—Haikal had delivered the same substance to Saridewi on five or six occasions—and on the highly suspect circumstances of handling. Additionally, the court considered that Haikal earned RM500 for each delivery, supporting the inference that he was acting as a supplier rather than an unwitting courier.
Although the defence made no submission at the close of the prosecution’s case, the court still had to decide whether the prosecution had proved the charges beyond a reasonable doubt and whether the presumptions were rebutted. The court’s reasoning, as reflected in the extract, indicates that it found the prosecution evidence sufficient on both the actus reus (possession/delivery) and the requisite knowledge, and that the defences did not create reasonable doubt or rebut the statutory presumptions.
What Was the Outcome?
At the conclusion of the joint trial, the court was satisfied that the prosecution proved the charges against both accused persons beyond a reasonable doubt. Both Saridewi and Haikal were convicted. The extract indicates that the court delivered brief grounds for the convictions and then sentenced both accused persons on 6 July 2018.
In the grounds issued on 14 September 2018, the court set out its full reasoning and confirmed that it rejected the defences advanced by both accused persons, including challenges to the chain of drug exhibits, arguments about mental state affecting statement accuracy, and the defence of consumption for Saridewi. The practical effect of the decision is that the convictions and sentences imposed on 6 July 2018 were upheld on the basis of the court’s detailed assessment of evidence and statutory presumptions.
Why Does This Case Matter?
This case matters for practitioners because it illustrates how the High Court evaluates the prosecution’s evidence in MDA trafficking cases where the defence attempts to undermine the chain of exhibits and the reliability of investigative statements. The court’s acceptance of the integrity of custody and its rejection of speculative substitution arguments reinforce the importance of operational safeguards and evidential documentation in covert CNB operations.
From a doctrinal perspective, the decision demonstrates the practical operation of the MDA presumptions. For Saridewi, the presumption of trafficking under s 17 was not rebutted by a consumption defence. The court’s analysis highlights that rebutting the presumption requires more than assertions of personal use; it requires coherent and credible evidence consistent with the quantity seized, the alleged consumption pattern, and the accused’s circumstances, including financial means and the internal consistency of statements. For Haikal, the presumption of knowledge under s 18(2) was supported by admissions and contextual evidence, including the pattern of deliveries and payment.
Finally, the case is useful for lawyers dealing with mental state arguments in statement-taking. While mental conditions may be relevant to the weight of statements, this decision shows that courts will scrutinise whether the evidence establishes substantial impairment at the material time. Defence reliance on expert opinions will be tested against the factual record and the prosecution’s countervailing evidence.
Legislation Referenced
- Misuse of Drugs Act (Cap 185, 2008 Rev Ed) (“MDA”), including ss 5(1)(a), 5(2), 17, 18(2)
- Criminal Procedure Code (Cap 68, 2012 Rev Ed) (“CPC”), including s 267(1)
Cases Cited
Source Documents
This article analyses [2018] SGHC 204 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.